SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
70 hedge funds and large institutions have $105M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 17 closing their positions.
Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
19
Reduced
11
Closed
17
Calls
$144K
Puts
$17K
Net Calls
+$127K
Net Calls Change
-$32K
Top Buyers
Top Sellers
1 |
DMKJ
1
David M. Knott Jr
|
$0 |
2 |
2
Millennium Management
New York
|
$325K |
3 |
3
Goldman Sachs
New York
|
$1.35M |
4 |
4
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$81.9K |
5 |
5
Jane Street
New York
|
$202K |